Bicara Therapeutics, a spinout of Kiran Mazumdar-Shaw's Biocon, raises $108m

Bicara Therapeutics, a spinout of Kiran Mazumdar-Shaw's Biocon, raises $108m

Bloomberg Creative Photos/Bloomberg

07 March, 2023

Edited by: Joymitra Rai

Bicara Therapeutics Biocon Eight Roads Ventures F-Prime Capital Invus Piper Heartland Healthcare Capital PremjiInvest RA Capital Management Red Tree Venture Capital

Printed by Unregistered user on Sun, 07 Dec 2025 05:48:02 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

India's Biocon Biologics in fundraising talks with Baring PE Asia

India's Serum to get 15% stake in Biocon Biologics for 100 million vaccine doses a year

Read more from India

Meesho raises $28b in India IPO as institutional investors pile in

Zoho, Lingotto pump $45m into Indian electric bike company Ultraviolette